Description: The Sarigam facility demonstrates Taj Pharma’s unmatched production strength and operational excellence. The plant is capable of producing: 120 million tablets per month 40 million capsules per month 36,000 kilograms of dry blended powders monthly 20 million effervescent tablets monthly 60 million units of oral jelly per month 40 million creams and ointments per month 3 million oral sachets per month This extraordinary capacity allows Taj Pharma India Ltd. to serve diverse therapeutic segments, including cardiovascular, anti-infective, oncology, gastroenterology, diabetology, neurology, dermatology, and nutraceuticals. By maintaining robust production consistency and on-time delivery, the company ensures its strong foothold in both regulated and semi-regulated markets. Certifications and Compliance: Setting Global Standards Taj Pharma’s Sarigam facility is certified by leading national and international authorities, underscoring its unwavering dedication to compliance and quality. The plant holds the following certifications: WHO-GMP (World Health Organization – Good Manufacturing Practices) GMP (Good Manufacturing Practice) GLP (Good Laboratory Practice) ISO 9001:2018 Certification PIC/S (Pharmaceutical Inspection Co-operation Scheme) SGS Certification Furthermore, the company is in the process of acquiring EU-GMP certification, a testament to its readiness to cater to the European pharmaceutical market. Each certification serves as a seal of trust, confirming that Taj Pharma adheres to the strictest standards of manufacturing excellence, product safety, and quality assurance.
Dimensions: 2560 x 1442
File Type: png
File Size: 2 MB
